Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Nighttime Blood Pressure in African Americans
NCT01114373Phase 2Completed
- Sponsor
- Emory University
- Start
- Jun 2010
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of melatonin in hypertension (HTN) (2 arms), sponsored by Emory University. Primary endpoints: Mean Nighttime Systolic Blood Pressure at 4 weeks and Mean Nighttime Diastolic Blood Pressure at 4 weeks. Started Jun 2010; status: completed.
02
Drugs
melatonin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01114373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114373.